The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lanciotti, M ^a   Masieri, L ^a   Raspollini, M R ^a   Minervini, A ^a   Mari, A ^a   Comito, G ^b   Giannoni, E ^b   Carini, M ^a   Chiarugi, P ^b   Serni, S ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER SURGERY; CELL DENSITY; EXTRACAPSULAR TUMOR EXTENSION; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR GROWTH; BIOPSY; CANCER STAGING; DISEASE FREE SURVIVAL; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATIC NEOPLASMS;

AGED; BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84897567467     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/486798     Document Type: Article

References (15)

1. Philip M., Rowley D. A., Schreiber H., Inflammation as a tumor promoter in cancer induction. Seminars in Cancer Biology 2004 14 6 433 439 2-s2.0-5444256371 10.1016/j.semcancer.2004.06.006 (Pubitemid 39360991)
2. Lu H., Ouyang W., Huang C., Inflammation, a key event in cancer development. Molecular Cancer Research 2006 4 4 221 233 2-s2.0-33646160623 10.1158/1541-7786.MCR-05-0261
3. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009. CA Cancer Journal for Clinicians 2009 59 4 225 249 2-s2.0-67650874081 10.3322/caac.20006
4. MacLennan G. T., Eisenberg R., Fleshman R. L., Taylor J. M., Fu P., Resnick M. I., Gupta S., The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. Journal of Urology 2006 176 3 1012 1016 2-s2.0-33746521926 10.1016/j.juro.2006.04.033 (Pubitemid 44142579)
5. De Marzo A. M., Marchi V. L., Epstein J. I., Nelson W. G., Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. American Journal of Pathology 1999 155 6 1985 1992 2-s2.0-0032805744
6. Redente E. F., Dwyer-Nield L. D., Merrick D. T., Raina K., Agarwal R., Pao W., Rice P. L., Shroyer K. R., Malkinson A. M., Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. American Journal of Pathology 2010 176 6 2972 2985 2-s2.0-77953183233 10.2353/ajpath.2010.090879
7. Carini M., Masieri L., Minervini A., Lapini A., Serni S., Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localized prostate cancer. European Urology 2008 53 3 554 563 2-s2.0-38749145590 10.1016/j.eururo.2007.07.004 (Pubitemid 351178986)
8. Epstein J. I., Allsbrook W. C. Jr., Amin M. B., Egevad L. L., Bastacky S., López Beltrán A., Berner A., Billis A., Boccon-Gibod L., Cheng L., Civantos F., Cohen C., Cohen M. B., Datta M., Davis C., Delahunt B., Delprado W., Eble J. N., Foster C. S., Furusato M., Gaudin P. B., Grignon D. J., Humphrey P. A., Iczkowski K. A., Jones E. C., Lucia S., McCue P. A., Nazeer T., Oliva E., Pan C.-C., Pizov G., Reuter V., Samaratunga H., Sebo T., Sesterhenn I., Shevchuk M., Srigley J. R., Suzigan S., Takahashi H., Tamboli P., Tan P. H., Tètu B., Tickoo S., Tomaszewski J. E., Troncoso P., Tsuzuki T., True L. D., Van Der Kwast T., Wheeler T. M., Wojno K. J., Young R. H., The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. American Journal of Surgical Pathology 2005 29 9 1228 1242 2-s2.0-24144493035 10.1097/01.pas.0000173646.99337.b1 (Pubitemid 41232997)
9. Eble J. N., Sauter G., Epstein J. I., Sesterhenn I. A., World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 Lyon, France IARC Press
10. AJCC, Cancer Staging Manual 2010 7th New York, NY, USA Springer
11. Nonomura N., Takayama H., Nakayama M., Nakai Y., Kawashima A., Mukai M., Nagahara A., Aozasa K., Tsujimura A., Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. BJU International 2011 107 12 1918 1922 2-s2.0-79957822818 10.1111/j.1464-410X.2010.09804.x
12. Shimura S., Yang G., Ebara S., Wheeler T. M., Frolov A., Thompson T. C., Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Research 2000 60 20 5857 5861 2-s2.0-0034667386
13. Sica A., Schioppa T., Mantovani A., Allavena P., Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. European Journal of Cancer 2006 42 6 717 727 2-s2.0-33645991795 10.1016/j.ejca.2006.01.003
14. Sica A., Larghi P., Mancino A., Rubino L., Porta C., Totaro M. G., Rimoldi M., Biswas S. K., Allavena P., Mantovani A., Macrophage polarization in tumour progression. Seminars in Cancer Biology 2008 18 5 349 355 2-s2.0-48349102876 10.1016/j.semcancer.2008.03.004
15. Raina K., Singh R. P., Agarwal R., Agarwal C., Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Research 2007 67 12 5976 5982 2-s2.0-34250827944 10.1158/0008-5472.CAN-07-0295 (Pubitemid 46985034)